Global Gastroesophageal Reflux Disease Therapeutics Market Insights and Forecast to 2028

Table Of Contents

1 Report Business Overview

1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Antacids 1.2.3 H2 Receptor Blockers 1.2.4 Proton Pump Inhibitors (PPIs) 1.2.5 Pro-kinetic Agents 1.2.6 Others 1.3 Market by Application 1.3.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacy 1.3.3 Drug Stores 1.3.4 General Stores 1.3.5 Supermarkets 1.4 Study Objectives 1.5 Years Considered2 Global Growth Trends 2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Perspective (2017-2028) 2.2 Gastroesophageal Reflux Disease Therapeutics Growth Trends by Region 2.2.1 Gastroesophageal Reflux Disease Therapeutics Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Region (2017-2022) 2.2.3 Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Region (2023-2028) 2.3 Gastroesophageal Reflux Disease Therapeutics Market Dynamics 2.3.1 Gastroesophageal Reflux Disease Therapeutics Industry Trends 2.3.2 Gastroesophageal Reflux Disease Therapeutics Market Drivers 2.3.3 Gastroesophageal Reflux Disease Therapeutics Market Challenges 2.3.4 Gastroesophageal Reflux Disease Therapeutics Market Restraints3 Competition Landscape by Key Players 3.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Revenue 3.1.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Revenue (2017-2022) 3.1.2 Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Players (2017-2022) 3.2 Global Gastroesophageal Reflux Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Gastroesophageal Reflux Disease Therapeutics Revenue 3.4 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio 3.4.1 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease Therapeutics Revenue in 2021 3.5 Gastroesophageal Reflux Disease Therapeutics Key Players Head office and Area Served 3.6 Key Players Gastroesophageal Reflux Disease Therapeutics Product Solution and Service 3.7 Date of Enter into Gastroesophageal Reflux Disease Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans4 Gastroesophageal Reflux Disease Therapeutics Breakdown Data by Type 4.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Type (2017-2022) 4.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Type (2023-2028)5 Gastroesophageal Reflux Disease Therapeutics Breakdown Data by Application 5.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Application (2017-2022) 5.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Application (2023-2028)6 North America 6.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size (2017-2028) 6.2 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Type 6.2.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022) 6.2.2 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2023-2028) 6.2.3 North America Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2017-2028) 6.3 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Application 6.3.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022) 6.3.2 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2023-2028) 6.3.3 North America Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2017-2028) 6.4 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country 6.4.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2017-2022) 6.4.2 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada7 Europe 7.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size (2017-2028) 7.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type 7.2.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022) 7.2.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2023-2028) 7.2.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2017-2028) 7.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application 7.3.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022) 7.3.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2023-2028) 7.3.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2017-2028) 7.4 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country 7.4.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2017-2022) 7.4.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries8 Asia-Pacific 8.1 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size (2017-2028) 8.2 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Type 8.2.1 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2017-2028) 8.3 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Application 8.3.1 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2017-2028) 8.4 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region 8.4.1 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size (2017-2028) 9.2 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Type 9.2.1 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022) 9.2.2 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2023-2028) 9.2.3 Latin America Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2017-2028) 9.3 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Application 9.3.1 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022) 9.3.2 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2023-2028) 9.3.3 Latin America Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2017-2028) 9.4 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country 9.4.1 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2017-2022) 9.4.2 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil10 Middle East & Africa 10.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size (2017-2028) 10.2 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Type 10.2.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2017-2028) 10.3 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Application 10.3.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2017-2028) 10.4 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country 10.4.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE11 Key Players Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Company Details 11.1.2 AstraZeneca Business Overview 11.1.3 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Introduction 11.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2017-2022) 11.1.5 AstraZeneca Recent Developments 11.2 Eisai 11.2.1 Eisai Company Details 11.2.2 Eisai Business Overview 11.2.3 Eisai Gastroesophageal Reflux Disease Therapeutics Introduction 11.2.4 Eisai Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2017-2022) 11.2.5 Eisai Recent Developments 11.3 Takeda Pharmaceutical 11.3.1 Takeda Pharmaceutical Company Details 11.3.2 Takeda Pharmaceutical Business Overview 11.3.3 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction 11.3.4 Takeda Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2017-2022) 11.3.5 Takeda Pharmaceutical Recent Developments 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Details 11.4.2 GlaxoSmithKline Business Overview 11.4.3 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Introduction 11.4.4 GlaxoSmithKline Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2017-2022) 11.4.5 GlaxoSmithKline Recent Developments 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Introduction 11.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2017-2022) 11.5.5 Johnson & Johnson Recent Developments 11.6 Daewoong Pharmaceutical 11.6.1 Daewoong Pharmaceutical Company Details 11.6.2 Daewoong Pharmaceutical Business Overview 11.6.3 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction 11.6.4 Daewoong Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2017-2022) 11.6.5 Daewoong Pharmaceutical Recent Developments 11.7 Ironwood Pharmaceuticals 11.7.1 Ironwood Pharmaceuticals Company Details 11.7.2 Ironwood Pharmaceuticals Business Overview 11.7.3 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Introduction 11.7.4 Ironwood Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2017-2022) 11.7.5 Ironwood Pharmaceuticals Recent Developments12 Analyst's Viewpoints/Conclusions13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer